Overall rank by patents
#678
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Boehringer Ingelheim International GmbH
USPTO PatentsView assignee record — 662 granted patents across 61 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
662
Total patents granted
61
CPC technology areas
17.1
Avg claims per patent
-35%
5-year filing velocity
Portfolio overview
Boehringer Ingelheim International GmbH has been granted 662 US utility patents between 2015 and 2025, placing Boehringer Ingelheim International GmbH at rank #678 across all assignees tracked by PlainPatent. This portfolio spans 61 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.1 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Boehringer Ingelheim International GmbH is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 63.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 260 grants, compared with 402 in the 2015–2019 window — a -35% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Boehringer Ingelheim International GmbH's 17.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 61 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Boehringer Ingelheim International GmbH against peers pursuing similar technology classes.
How does Boehringer compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Boehringer Ingelh… ◀ 662
Boehringer Ingelheim International GmbH
662 patents
What this shows Boehringer holds 662 patents — placing it at rank #678 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 148 | 22.4% |
| 2016 | 85 | 12.8% |
| 2017 | 53 | 8.0% |
| 2018 | 61 | 9.2% |
| 2019 | 55 | 8.3% |
| 2020 | 48 | 7.3% |
| 2021 | 45 | 6.8% |
| 2022 | 35 | 5.3% |
| 2023 | 41 | 6.2% |
| 2024 | 55 | 8.3% |
| 2025 | 36 | 5.4% |
Which technologies does Boehringer Ingelheim International GmbH patent most?
C07K— PEPTIDES 101
Top 15 of 61 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does Boehringer Ingelheim International GmbH hold?
Boehringer Ingelheim International GmbH holds 662 US granted patents filed between 2015 and 2025, spanning 61 technology areas.
What is Boehringer Ingelheim International GmbH's Innovation Score?
Boehringer Ingelheim International GmbH has an Innovation Score of 63.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Boehringer Ingelheim International GmbH focus on?
Boehringer Ingelheim International GmbH's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 468 patents. The company has filed patents in 61 CPC subclasses total.
Is Boehringer Ingelheim International GmbH's patent filing rate increasing or decreasing?
Boehringer Ingelheim International GmbH's recent filing velocity is -35% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Boehringer Ingelheim International GmbH's patents?
Boehringer Ingelheim International GmbH's patents average 17.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the Boehringer Ingelheim International GmbH patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
A61P technology
Boehringer Ingelheim International GmbH's primary CPC class — all holders and yearly trends
Top 50 patent holders
See where Boehringer Ingelheim International GmbH ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
